A panel of experts discuss the value of clinical pathways in MM disease management. Ryan Haumschild, PharmD, MS, MBA: Let’s talk about clinical pathways. We’ve seen pathways continue to emerge. One ...
Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...
In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback